The frequency of defective genomes in Omicron differs from that of the Alpha, Beta and Delta variants
| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Campos Martinez, Carolina |
| dc.contributor.author | Saubí Roca, Narcís |
| dc.contributor.author | Rodríguez Frias, Francisco |
| dc.contributor.author | Rando Segura, Ariadna |
| dc.contributor.author | Colomer-Castell, Sergi |
| dc.contributor.author | Garcia-Cehic, Damir |
| dc.contributor.author | Parés-Badell, Oleguer |
| dc.contributor.author | ADOMBI, Caroline Mélanie |
| dc.contributor.author | QUER, JOSEP |
| dc.contributor.author | Piñana, María |
| dc.contributor.author | González-Sánchez, Alejandra |
| dc.contributor.author | Esperalba, Juliana |
| dc.contributor.author | Codina, María Gema |
| dc.contributor.author | Pumarola Suñe, Tomàs |
| dc.contributor.author | Gregori Font, Josep |
| dc.contributor.author | Esteban Mur, Juan Ignacio |
| dc.contributor.author | BORRAS BERMEJO, BLANCA |
| dc.contributor.author | Ibañez Lligoña, Marta |
| dc.contributor.author | Antón Pagarolas, Andrés |
| dc.contributor.author | Andrés Vergés, Cristina |
| dc.date.accessioned | 2023-02-01T12:55:58Z |
| dc.date.available | 2023-02-01T12:55:58Z |
| dc.date.issued | 2022-12-29 |
| dc.identifier.citation | Campos C, Colomer-Castell S, Garcia-Cehic D, Gregori J, Andrés C, Piñana M, et al. The frequency of defective genomes in Omicron differs from that of the Alpha, Beta and Delta variants. Sci Rep. 2022 Dec 29;12:22571. |
| dc.identifier.issn | 2045-2322 |
| dc.identifier.uri | https://hdl.handle.net/11351/8945 |
| dc.description | Evolution; Genetics; Molecular biology |
| dc.description.abstract | The SARS-CoV-2 Omicron variant emerged showing higher transmissibility and possibly higher resistance to current COVID-19 vaccines than other variants dominating the global pandemic. In March 2020 we performed a study in clinical samples, where we found that a portion of genomes in the SARS-CoV-2 viral population accumulated deletions immediately before the S1/S2 cleavage site (furin-like cleavage site, PRRAR/S) of the spike gene, generating a frameshift and appearance of a premature stop codon. The main aim of this study was to determine the frequency of defective deletions in prevalent variants from the first to sixth pandemic waves in our setting and discuss whether the differences observed might support epidemiological proposals. The complete SARS-CoV-2 spike gene was deeply studied by next-generation sequencing using the MiSeq platform. More than 90 million reads were obtained from respiratory swab specimens of 78 COVID-19 patients with mild infection caused by the predominant variants circulating in the Barcelona city area during the six pandemic waves: B.1.5, B.1.1, B.1.177, Alpha, Beta, Delta, and Omicron. The frequency of defective genomes found in variants dominating the first and second waves was similar to that seen in Omicron, but differed from the frequencies seen in the Alpha, Beta and Delta variants. The changing pattern of mutations seen in the various SARS-CoV-2 variants driving the pandemic waves over time can affect viral transmission and immune escape. Here we discuss the putative biological effects of defective deletions naturally occurring before the S1/S2 cleavage site during adaption of the virus to human infection. |
| dc.language.iso | eng |
| dc.publisher | Nature Portfolio |
| dc.relation.ispartofseries | Scientific Reports;12 |
| dc.rights | Attribution 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
| dc.source | Scientia |
| dc.subject | COVID-19 (Malaltia) - Vacunació |
| dc.subject | Immunoglobulines |
| dc.subject.mesh | Coronavirus Infections |
| dc.subject.mesh | Viral Vaccines |
| dc.subject.mesh | Antibodies, Neutralizing |
| dc.title | The frequency of defective genomes in Omicron differs from that of the Alpha, Beta and Delta variants |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.1038/s41598-022-24918-8 |
| dc.subject.decs | infecciones por Coronavirus |
| dc.subject.decs | vacunas víricas |
| dc.subject.decs | anticuerpos neutralizantes |
| dc.relation.publishversion | https://doi.org/10.1038/s41598-022-24918-8 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Campos C, Quer J] Grup de Recerca de les Malalties Hepàtiques, Unitat Hepàtica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Colomer-Castell S] Grup de Recerca de les Malalties Hepàtiques, Unitat Hepàtica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Garcia-Cehic D, Gregori J] Grup de Recerca de les Malalties Hepàtiques, Unitat Hepàtica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. [ndrés C, Piñana M, González-Sánchez A, Esperalba J, Codina MG, Rando-Segura A, Saubí N] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Borràs B, Parés-Badell O] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Medicina Preventiva, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Adombi CM, Ibañez-Lligoña M] Grup de Recerca de les Malalties Hepàtiques, Unitat Hepàtica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Esteban JI] Grup de Recerca de les Malalties Hepàtiques, Unitat Hepàtica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Rodriguez-Frías F] Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Bioquímica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Pumarola T, Antón A] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Microbiologia, Universitat Autònoma de Barcelona, Bellaterra, Spain |
| dc.identifier.pmid | 36581627 |
| dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/RD16%2F0016%2F0003 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |
Files in this item
This item appears in the following Collection(s)
-
Col·lecció especial COVID-19 [945]
-
HVH - Articles científics [4476]
-
VHIR - Articles científics [1751]




